Skip to content

Envoy Medical COCH Q4 2025 Annual earnings

Reported March 23, 2026 · Before market open

Revenue$100.0KBeat by $70.0K
EPS-$0.26Miss by $0.02
Revenue estimate$30.0K
EPS estimate-$0.24

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$100.0K
EPS estimate-$0.09

Financials

Q4 2025

Income statement

See full
Revenue$75.0K+78.6%
Gross profit-$136.0K-18.3%
Operating income-$6.4M-40.4%
Net income-$6.6M-42.6%
EPS (diluted)-$0.26+35.0%

Balance sheet

See full
Cash & equivalents$3.7M-31.8%
Total debt$919.0K-2.8%
Total equity-$12.2M+35.5%
Total assets$8.6M-25.8%

Cash flow

See full
Operating cash flow-$5.7M-11.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$19.13M-33.9%
Enterprise value$16.31M-33.2%
P/S79.4×-49.3×

Profitability

See full
Gross margin-262.7%+43.9pp
Operating margin-9,240.7%+800pp
Net margin-9,857.3%+703pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Current ratio0.5×-0.6×

Versus estimates

Ask the moment Envoy Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Envoy Medical report Q4 2025 earnings?
Envoy Medical (COCH) reported Q4 2025 earnings on March 23, 2026 before market open.
What were Envoy Medical's Q4 2025 revenue and EPS?
Envoy Medical reported revenue of $100.0K and eps of $-0.26 for Q4 2025.
Did Envoy Medical beat estimates in Q4 2025?
Revenue beat the consensus estimate of $30.0K by $70.0K. EPS missed the consensus estimate of $-0.24 by $0.02.
How did Envoy Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 138.1% from $42.0K a year earlier and eps grew 42.2% from $-0.45.
Where can I find Envoy Medical's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001213900-26-032683) directly on SEC EDGAR. The filing index links above go to sec.gov.